Recce Pharmaceuticals Ltd Cash Flow Quality Index

Latest as of June 2026: 0.21x

Recce Pharmaceuticals Ltd cash flow quality index. Recce Pharmaceuticals Ltd (RCE) has a Cash Flow Quality Index of 0.21x as of June 2026. Operating cash flow of AU$341.10K is below net income of AU$1.60 Million, suggesting accrual-heavy earnings not yet converted to cash. See RCE free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

0.21x

Operating CF / Net Income

Operating Cash Flow

AU$341.10K

AUD

Net Income

AU$1.60 Million

AUD

Data as of

Jun 2026

Most recent filing

Recce Pharmaceuticals Ltd Cash Flow Quality Index by Year (None–None)

Recce Pharmaceuticals Ltd cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Recce Pharmaceuticals Ltd. For the full cash flow conversion analysis, see Recce Pharmaceuticals Ltd cash conversion from operations.

Year	Quality Index	Operating CF (AUD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.